跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Emend - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Emend
Approved
STANDARD
Emend
Alkermes Pharma Ireland Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1e22373fdd39f230
Company
Alkermes Pharma Ireland Ltd.
Type
Standard
Approval Details
Approval Id
1e22373fdd39f230
Drug Approval Philippines Name
Emend
Product Name
Emend
Registration Number
DR-XY44900
Brand Name
Emend
Generic Name
Aprepitant
Dosage Form
capsule
Dosage Strength
80mg + 125mg
Manufacturer
Alkermes Pharma Ireland Ltd.
Importer
Merck Sharp & Dohme (I.A.) LLC
Company Detail Path
/organization/alkermes-pharma-ireland-ltd
Issuance Date
19 November 2020
Expiry Date
27 November 2025
Pharmacologic Category
Anti Emetic/ Substance P Neurokinin 1 Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1e22373fdd39f230
Type
Standard
Back to Philippines FDA Approvals